Eurazeo has entered into exclusive negotiations to sell its stake in pharmaceutical and specialty ingredients producer Seqens to SK Capital, as well the company’s existing shareholders, which include Ardian.
Eurazeo to sell Seqens stake to SK Capital et al.
Most Popular
